Patrick A Zweidler-McKay Selected Research

Patrick A Zweidler-McKay Research Topics

Disease

18	Neoplasms (Cancer) 01/2020 - 12/2005
12	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 05/2024 - 12/2005
9	Leukemia 04/2022 - 12/2005
6	Neuroblastoma 05/2012 - 07/2009
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2022 - 09/2010
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2023 - 01/2014
2	Hematologic Neoplasms (Hematological Malignancy) 04/2022 - 05/2015
2	Residual Neoplasm 01/2020 - 01/2017
2	Pneumonia (Pneumonitis) 01/2016 - 04/2012
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2014 - 08/2009
1	Lymphoma (Lymphomas) 01/2019
1	Down Syndrome (Down's Syndrome) 07/2018
1	Acute Megakaryoblastic Leukemia (Leukemia, Megakaryocytic) 07/2018
1	Philadelphia Chromosome 01/2017
1	Neutropenia 01/2016
1	B-Cell Lymphoma (Lymphoma, B Cell) 02/2013
1	Eosinophilia 04/2012
1	Hypoxia (Hypoxemia) 01/2011
1	Ewing Sarcoma (Sarcoma, Ewing) 02/2010
1	Carcinogenesis 07/2009
1	Osteosarcoma (Osteogenic Sarcoma) 05/2008

Drug/Important Bio-Agent (IBA)

5	Phosphotransferases (Kinase)IBA 07/2018 - 07/2009
3	Notch ReceptorsIBA 01/2014 - 05/2012
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 01/2013
2	Cytokine Receptors (Cytokine Receptor)IBA 01/2017 - 01/2017
2	Decitabine FDA Link 01/2013 - 05/2012
2	Messenger RNA (mRNA)IBA 04/2012 - 03/2011
2	Adenosine Triphosphate (ATP)IBA 02/2012 - 06/2011
2	Sirolimus (Rapamycin)FDA Link 02/2012 - 06/2011
2	Tyrosine (L-Tyrosine)FDA Link 07/2010 - 05/2010
2	ErbB Receptors (EGF Receptor)IBA 07/2010 - 05/2010
2	LigandsIBA 05/2008 - 12/2005
1	Bortezomib (Velcade)FDA Link 05/2024
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 04/2022
1	brusatolIBA 04/2022
1	Daunorubicin (Cerubidine)FDA LinkGeneric 04/2022
1	Methotrexate (Mexate)FDA LinkGeneric 10/2020
1	Histones (Histone)IBA 01/2020
1	5-Methylcytosine (5 Methylcytosine)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	DioxygenasesIBA 01/2020
1	Immunoconjugates (Immunoconjugate)IBA 01/2019
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2019
1	Etoposide (VP 16)FDA LinkGeneric 01/2019
1	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 01/2019
1	Core Binding Factors (Core-Binding Factor)IBA 07/2018
1	TropomyosinIBA 07/2018
1	Cytotoxins (Cytolysins)IBA 01/2016
1	venetoclaxIBA 12/2015
1	FucosyltransferasesIBA 05/2015
1	Guanosine Diphosphate Fucose (GDP Fucose)IBA 05/2015
1	EnzymesIBA 05/2015
1	Notch1 ReceptorIBA 01/2014
1	Gamma Secretase Inhibitors and ModulatorsIBA 01/2014
1	Interleukin-10 (Interleukin 10)IBA 04/2012
1	MicroRNAs (MicroRNA)IBA 04/2012
1	Interleukin-4 (Interleukin 4)IBA 04/2012
1	Interleukin-5 (Interleukin 5)IBA 04/2012
1	Oxygen (Dioxygen)IBA 02/2012
1	MTOR InhibitorsIBA 02/2012
1	Lactic Acid (Lactate)FDA LinkGeneric 02/2012
1	Topotecan (Hycamtin)FDA LinkGeneric 03/2011
1	trkB ReceptorIBA 03/2011
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 03/2011
1	ProdrugsIBA 01/2011
1	PR-104IBA 01/2011
1	Actins (F Actin)IBA 09/2010
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 07/2010
1	Canertinib (CI 1033)IBA 07/2010
1	Isotretinoin (Accutane)FDA LinkGeneric 05/2010
1	vandetanib (ZD6474)IBA 05/2010
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 05/2010
1	Small Interfering RNA (siRNA)IBA 02/2010
1	delta proteinIBA 02/2010
1	DesminIBA 02/2010
1	HLA Antigens (Human Leukocyte Antigens)IBA 08/2009
1	Nerve Growth Factors (Neurotrophins)IBA 07/2009

Therapy/Procedure

20	Therapeutics 05/2024 - 12/2005
4	Drug Therapy (Chemotherapy) 01/2020 - 03/2011
2	Hematopoietic Stem Cell Transplantation 01/2020 - 08/2009
2	Remission Induction 01/2017 - 01/2016
2	Transplantation 05/2015 - 01/2014
1	Aftercare (After-Treatment) 03/2011
1	Stem Cell Transplantation 09/2010
1	Injections 02/2010
1	Oral Administration 07/2009